We are live on ! Find out more
IVMX

Institutional Venture Management XVI Portfolio holdings

AUM $1.18M
1-Year Est. Return 156.01%
This Fund
S&P 500
This Quarter Est. Return
+67.77%
1 Year Est. Return
+156.01%
3 Year Est. Return
+522.88%
5 Year Est. Return
+246.9%
10 Year Est. Return
AUM
$86.1M
AUM Growth
+$10.1M
Cap. Flow
-$28.5M
Cap. Flow %
-33.06%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.86%
2 Consumer Discretionary 6.14%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIMS icon
1
Hims & Hers Health
HIMS
$7.39B
$80.8M 93.86%
5,222,570
-2,500,000
-32% -$28.2M
LVLU icon
2
Lulu's Fashion Lounge
LVLU
$37.8M
$5.28M 6.14%
251,573
HCP
3
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-11,385
Closed -$269K

Similar funds

Institutional Venture Management XVI's Q1 2024 Portfolio in Review

As of Q1 2024, Institutional Venture Management XVI held 3 positions worth $86.1M, up 13% from $76M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Institutional Venture Management XVI withdrew a net $28.5M in Q1 2024, closing 1 position and reducing 1 holding. Its most notable exit was HashiCorp, Inc. Class A Common Stock, an estimated $269K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 90% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Institutional Venture Management XVI's biggest Q1 2024 reduction was Hims & Hers Health, cutting an estimated $28.2M.
  • Institutional Venture Management XVI fully exited HashiCorp, Inc. Class A Common Stock in Q1 2024, selling an estimated $269K.
  • Institutional Venture Management XVI's ten largest holdings make up 100% of its $86.1M portfolio in Q1 2024.
  • Institutional Venture Management XVI opened 0 new positions and closed 1 in Q1 2024.
  • Institutional Venture Management XVI's portfolio value rose 13% quarter-over-quarter to $86.1M.

Based on Institutional Venture Management XVI's 13F filing for Q1 2024, filed 15 May 2024.